STAT Plus: Eli Lilly places the team from a startup it bought in January in charge of its cancer research
KRISTOFFER TRIPPLAAR/AP
The drug giant said it is renaming its early cancer drug development arm Loxo Oncology at Lilly, and that the new unit will be helmed by Loxo’s former CEO.
No hay comentarios:
Publicar un comentario